Showing results (181-190 of 6,950) with videos related to
Sort By:
Pageof 695
Journal of Clinical Pharmacology|May 18, 2019
Acetaminophen Protein Adducts in Hospitalized Children Receiving Multiple Doses of AcetaminophenSibo Jiang, Valvanera Vozmediano, Susan M Abdel-Rahman, et al.Journal of Clinical Pharmacology|May 29, 2019
Effects of Ketoconazole, a CYP4F2 Inhibitor, and CYP4F2*3 Genetic Polymorphism on Pharmacokinetics of Vitamin K1Jin-Woo Park, Kyoung-Ah Kim, Ji-Young ParkJournal of Clinical Pharmacology|April 23, 2022
Population Pharmacokinetics of Nifurtimox in Adult and Pediatric Patients With Chagas DiseaseIbrahim Ince, Klaas Prins, Stefan Willmann, et al.Journal of Clinical Pharmacology|April 14, 2022
Combinations of Drug Candidate Properties Affecting Development Success and Discontinuation for 5 Diseases: Lymphoma, Non-Small Cell Lung Cancer, Arthritis, Depression, and Alzheimer DiseaseShingo Yamaguchi, Mamoru NarukawaJournal of Clinical Pharmacology|September 1, 1986
Prophylaxis of migraine attacks with a calcium-channel blocker: flunarizine versus methysergideL Steardo, E Marano, P Barone, et al.Journal of Clinical Pharmacology|October 12, 2021
Effects of Renal Impairment on the Pharmacokinetics of Abrocitinib and Its MetabolitesEllen Q Wang, Vu Le, Jennifer A Winton, et al.Journal of Clinical Pharmacology|October 6, 2021
Time Above All Else: Pharmacodynamic Analysis of β-Lactams in Critically Ill PatientsKatie B Landmesser, Justin A Clark, David S BurgessJournal of Clinical Pharmacology|October 14, 2021
Pharmacokinetic Simulation Analysis of Less Frequent Nivolumab and Pembrolizumab Dosing: Pharmacoeconomic Rationale for Dose DeescalationCody J Peer, Brian L Heiss, Daniel A Goldstein, et al.Journal of Clinical Pharmacology|October 14, 2021
Intrapulmonary Pharmacokinetic Modeling and Simulation of Cefiderocol, a Parenteral Siderophore Cephalosporin, in Patients With Pneumonia and Healthy SubjectsNao Kawaguchi, Takayuki Katsube, Roger Echols, et al.Journal of Clinical Pharmacology|March 18, 2022
Current Understanding and Future Perspectives on Hyperprogressive Disease Highlight the Tumor MicroenvironmentMeiqi Li, Xianmei Zhong, Fukuan Du, et al.Pageof 695